Experimental Drug Reverses Osteoarthritis in Weeks in Animal Studies

Researchers have demonstrated that an experimental drug can reverse osteoarthritis damage in animal models within weeks, regenerating cartilage that was previously considered permanently destroyed. The breakthrough challenges the long-held medical assumption that joint degeneration is irreversible and opens a potential pathway to treatment for the 500 million people worldwide living with the condition. Human clinical trials are being planned, though researchers caution that animal results do not always translate to human outcomes.